AGI readiness for healthcare organisations

Healthcare organisations should prepare for increasingly capable AI, sometimes described as progress toward artificial general intelligence (AGI), even as the timeline remains uncertain. "AGI readiness" for healthcare means building governance, clinical, and operational frameworks flexible enough to handle AI systems that are substantially more capable than today's, without assuming any specific timeline.

What "more capable" looks like in healthcare

AI that can synthesise entire patient histories and generate comprehensive differential diagnoses. AI that can design treatment plans drawing on the full medical literature. AI-generated drug discovery and clinical trial design. AI that can engage in sustained clinical reasoning across complex cases. AI pathology and radiology approaching or exceeding specialist-level performance across all modalities. Each of these is already emerging in narrow forms; broader capability will amplify both benefits and governance challenges.

Governance frameworks that scale

Build AI governance that accommodates increasing capability: clinical governance integration, AI must be assessed through existing clinical governance structures, not parallel processes; validation requirements that scale with AI autonomy, the more autonomous the AI, the more rigorous the validation; human oversight proportionate to clinical risk, high-risk clinical decisions require human clinician oversight regardless of AI capability; liability frameworks that address increasingly capable AI; regulatory engagement, track FDA, MHRA, TGA approaches to increasingly autonomous AI medical devices.

Practical steps now

Implement an AI clinical governance framework that can accommodate new AI capabilities as they emerge. Establish clinical AI validation processes. Build board-level AI literacy for healthcare governance. Develop AI incident response procedures. Engage with regulatory developments (FDA's evolving SaMD framework, MHRA's AI regulation review). Participate in industry bodies developing healthcare AI standards (CHAI, WHO AI ethics guidance). The organisations that build robust governance now will be positioned to adopt more capable AI safely; the ones that wait will scramble.

Primary sources: FDA AI/ML Medical Devices · WHO AI Ethics Guidance

Related reading